Avencia Sánchez-Mejías earns Jump4Women grant from Foment del Treball and U.S. Consulate in Barcelona
Dr. Avencia Sánchez-Mejías, CEO and co-founder of Integra Therapeutics, is one of the 20 women entrepreneurs who earned the Jump Startup for Women in Deeptech (Jump4Women) grant from Foment del Treball and the U.S. Consulate General in Barcelona. Jump4Women is a newly created program to promote the growth of startups led by women in the […]
Spanish researchers to design proteins using AI to make advanced therapies more efficient
Researchers from the companies VIVEbiotech, Integra Therapeutics and OneChain Immunotherapeutics, the Department of Medicine and Life Sciences of the Pompeu Fabra University (UPF), the Institute of Molecular Biology of Barcelona (IBMB-CSIC) and the Center for Energy, Environmental and Technological Research (CIEMAT) have joined forces to design using artificial intelligence and produce next-generation viral particles to […]
Integra Therapeutics joins AseBio ‘Vida a la biotecnología’ campaign
Integra Therapeutics is one of the biotech companies that the Spanish Bioindustry Association (AseBio) has chosen for its new campaign #VidaALaBiotecnología, which aims to value the capacity of this strategic sector to grow, consolidate itself and unfold its potential in Spain. Biotechnology is crucial in responding to the challenges facing Europe thanks to its ability […]
Integra Therapeutics announces key additions to its Scientific Advisory Board
Integra Therapeutics has recently expanded its Scientific Advisory Board (SAB), made up of renowned experts from the US and Europe in artificial intelligence, drug discovery and clinical development in the gene therapy field. The SAB will provide strategic guidance on the company’s research and development efforts and strategy, particularly focused on the FiCAT gene-writing platform […]
Integra Therapeutics to present ex vivo and in vivo data for its FiCAT gene writing platform at Advanced Therapies Europe congress
Integra Therapeutics will present positive data from ex vivo and in vivo preclinical studies that demonstrates the potential of its FiCAT gene writing platform for developing advanced therapies in the field of paediatric hepatology at the Advanced Therapies Europe congress, taking place in Estoril (Portugal) from 5 to 7 September. Dr Avencia Sánchez-Mejías, CEO and […]
Integra Therapeutics CEO Avencia Sánchez-Mejías to speak at Global Synthetic Biology Conference
Integra Therapeutics CEO, Dr Avencia Sánchez-Mejías, will be a featured speaker at the Global Synthetic Biology Conference from May 23 to 25 in Oakland, California. Hosted by SynBioBeta, this is the biggest event for business and investment in the field of synthetic biology, showcasing the cutting-edge industrial developments that are transforming how we fuel, heal […]
Integra Therapeutics presents video ‘New FiCAT gene writing platform to cure diseases’
On 25 April, to celebrate DNA Day 2023, Integra Therapeutics launched a video explaining the new FiCAT gene writing platform developed by its scientific team. The video also explains the advances this entails in achieving more efficient and precise advanced therapies to cure patients through programmable DNA insertion to their genome. This year, DNA Day […]
Integra Therapeutics awarded Neotec grant to advance FiCAT platform in vivo deployment for gene therapy
Integra Therapeutics has been awarded a €335,000 non-refundable grant through the Spanish Ministry of Science and Innovation Neotec programme, managed by the Centre for the Development of Industrial Technology (CDTI). Neotec is a highly competitive programme that aims to foster technology and innovation for the development of companies based in Spain. In the 2022 call, […]
Integra Therapeutics, UPF and Josep Carreras Leukaemia Research Institute to develop CAR-T therapy for T-ALL
The public-private consortium made up of Integra Therapeutics, Pompeu Fabra University (UPF) and the Josep Carreras Leukaemia Research Institute (IJC) has received a grant of €1,230,732 from the Spanish State Research Agency (AEI) to develop new genetic engineering technology for a CAR-T therapy to treat T-cell acute lymphoblastic leukaemia (T-ALL). The funds are a competitive […]
Marc Güell wins the Spanish National Research Award for Young People 2022
Dr Marc Güell has received the Ángela Ruiz Robles 2022 National Research Award for Young People, in the field of technology transfer, awarded by the Ministry of Science and Innovation of Spain. He was recognised for his contributions in harnessing synthetic biology to generate new basic principles of molecular biology for the design of biological […]